Shanghai Hutchison Pharmaceuticals Limited
Shanghai Hutchison Pharmaceuticals Limited
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-01-06 | NCT07241520 | |
| Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction | Acute Myocardial Infarction (AMI); Percutaneous Coronary Intervention (PCI) | Not yet recruiting | Phase 4 | 2025-09-04 | NCT07153744 | |
| A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms | Abdominal Pain, Anorexia, Deglutition Disorders, Digestive System Diseases, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorder, digestive system disorder, dyskinesia of esophagus, dyspepsia, esophageal disorder, gastroesophageal reflux disease | Recruiting | Not stated | 2025-05-14 | NCT06755671 |